Clinical Trials in Pittsburgh

Showing 6421-6440 of 21,047 trials

Adjacent Segment Mechanics in Cervical Arthrodesis Patients

NCT03028402

This study aims to determine to what extent patient-specific factors, iatrogenic factors, and biomechanical factors influence cervical spine mechanics after single-level and two-level arthrodesis.

Intervertebral Disc Degeneration

University of Pittsburgh106 participantsStarted Apr 2016

Pittsburgh, Pennsylvania, United States

RECRUITINGNA< 1 mile

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

NCT05204888

Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at risk for moderate and severe exacerbations with a prior history of severe exacerbation requiring hospitalization within the past 6 weeks.

COPD

Temple University642 participantsStarted Feb 2022

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Jacksonville, Florida, United States +24 more locations

Adjacent Segment Mechanics in Cervical Arthrodesis Patients

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Find Trials by Condition in Pittsburgh

Framing Eighteen Coils in Cerebral Aneurysms Trial

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Rituximab + Immunotherapy in Follicular Lymphoma

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors